PT3071194T - Tratamento farmacológico de transtorno obcessivo-compulsivo utilizando estiripentol ou um composto semelhante - Google Patents
Tratamento farmacológico de transtorno obcessivo-compulsivo utilizando estiripentol ou um composto semelhanteInfo
- Publication number
- PT3071194T PT3071194T PT148207582T PT14820758T PT3071194T PT 3071194 T PT3071194 T PT 3071194T PT 148207582 T PT148207582 T PT 148207582T PT 14820758 T PT14820758 T PT 14820758T PT 3071194 T PT3071194 T PT 3071194T
- Authority
- PT
- Portugal
- Prior art keywords
- obsessive
- compulsive disorder
- pharmacological treatment
- pharmacological
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13306586.2A EP2875810A1 (en) | 2013-11-20 | 2013-11-20 | Pharmacological treatment of obsessive-compulsive disorder using Stiripentol or a similar compound |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3071194T true PT3071194T (pt) | 2022-11-03 |
Family
ID=49674249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT148207582T PT3071194T (pt) | 2013-11-20 | 2014-11-20 | Tratamento farmacológico de transtorno obcessivo-compulsivo utilizando estiripentol ou um composto semelhante |
Country Status (10)
Country | Link |
---|---|
US (1) | US10696647B2 (pt) |
EP (2) | EP2875810A1 (pt) |
JP (1) | JP6542788B2 (pt) |
CA (1) | CA2931162C (pt) |
DK (1) | DK3071194T3 (pt) |
ES (1) | ES2928895T3 (pt) |
HU (1) | HUE060188T2 (pt) |
PL (1) | PL3071194T3 (pt) |
PT (1) | PT3071194T (pt) |
WO (1) | WO2015075155A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019015362A2 (pt) * | 2017-02-10 | 2020-10-20 | Asarina Pharma Ab | 3-beta-hidroxi-5-alfa-pregnan-20-ona para uso em tratamento médico |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795893A (fr) | 1972-02-28 | 1973-06-18 | Unicler | Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique |
FR2253503A2 (en) * | 1973-12-10 | 1975-07-04 | Unicler | Ethylenic piperonal alcohols and ketones - anxiolytics, antidepressants, hypnotics and tranquillisers |
FR2253505A2 (en) * | 1973-12-10 | 1975-07-04 | Unicler | Alpha ethylenic alcohol and ketone derivs of pinacoline - modifiers of hexobarbital narcosis and anticonvulsants |
US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
WO2001064223A1 (en) * | 2000-02-29 | 2001-09-07 | Merck Frosst Canada & Co. | Method for treating or preventing depression |
AU2007299920A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | PPAR Mediated Modulation of Neurogenesis |
US20100184806A1 (en) * | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2732131A1 (en) * | 2008-08-06 | 2010-02-11 | Gosforth Centre (Holdings) Pty Ltd | Compositions and methods for treating psychiatric disorders |
ES2612115T3 (es) * | 2008-12-08 | 2017-05-12 | Biocodex | Compuestos y métodos para tratar trastornos del espectro autista |
-
2013
- 2013-11-20 EP EP13306586.2A patent/EP2875810A1/en not_active Withdrawn
-
2014
- 2014-11-20 ES ES14820758T patent/ES2928895T3/es active Active
- 2014-11-20 WO PCT/EP2014/075213 patent/WO2015075155A1/en active Application Filing
- 2014-11-20 JP JP2016554907A patent/JP6542788B2/ja active Active
- 2014-11-20 PT PT148207582T patent/PT3071194T/pt unknown
- 2014-11-20 HU HUE14820758A patent/HUE060188T2/hu unknown
- 2014-11-20 EP EP14820758.2A patent/EP3071194B1/en active Active
- 2014-11-20 US US15/038,011 patent/US10696647B2/en active Active
- 2014-11-20 CA CA2931162A patent/CA2931162C/en active Active
- 2014-11-20 PL PL14820758.2T patent/PL3071194T3/pl unknown
- 2014-11-20 DK DK14820758.2T patent/DK3071194T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP3071194A1 (en) | 2016-09-28 |
US20160289205A1 (en) | 2016-10-06 |
EP2875810A1 (en) | 2015-05-27 |
PL3071194T3 (pl) | 2022-12-05 |
JP2016537435A (ja) | 2016-12-01 |
WO2015075155A1 (en) | 2015-05-28 |
EP3071194B1 (en) | 2022-08-03 |
CA2931162C (en) | 2022-07-19 |
US10696647B2 (en) | 2020-06-30 |
ES2928895T3 (es) | 2022-11-23 |
DK3071194T3 (da) | 2022-10-24 |
CA2931162A1 (en) | 2015-05-28 |
HUE060188T2 (hu) | 2023-02-28 |
JP6542788B2 (ja) | 2019-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201801965RA (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
ZA201507733B (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
EP2968273A4 (en) | METHOD FOR THE TREATMENT OF MUSCLE DYSTROPHIES | |
PL3041945T3 (pl) | Wytwarzanie galakto-oligosacharydów | |
HK1215164A1 (zh) | 處理方法 | |
HK1224324A1 (zh) | 煤處理 | |
HK1224307A1 (zh) | 原毒素- 變體及其使用方法 | |
IL242533B (en) | Naltrexone cancer treatment | |
GB201304872D0 (en) | Treatment | |
HK1216391A1 (zh) | 組合治療 | |
IL241096B (en) | Treatment methods | |
EP2961401A4 (en) | METHOD FOR TREATING OTOTOXICITY | |
GB201607581D0 (en) | Treatment of cancer | |
HK1232118A1 (zh) | 癌症的治療 | |
GB201307310D0 (en) | Treatment | |
PT3071194T (pt) | Tratamento farmacológico de transtorno obcessivo-compulsivo utilizando estiripentol ou um composto semelhante | |
GB201322778D0 (en) | Method of treatment | |
GB201321115D0 (en) | Treatment | |
TWM475821U (en) | Structure of mosquito-catch | |
TWM475524U (en) | Structure of rivet-pulling | |
GB201314882D0 (en) | Method of treatment | |
GB201309238D0 (en) | Treatment | |
GB201312970D0 (en) | Treatment system | |
GB201322347D0 (en) | Treatment of cancer | |
GB201302523D0 (en) | Bath |